drug

CALY-002

Phase 1updated 3mo ago

by $NVS NOVARTIS AG

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying CALY-002

phase1Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitiscompletedn=73

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 27m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

CALY-002

Phase 1updated 3mo ago

by $NVS NOVARTIS AG

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying CALY-002

phase1Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitiscompletedn=73

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 27m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

CALY-002

all catalysts(0)

Trials studying CALY-002

News(0)

Report a data issue

comments(0)

CALY-002

all catalysts(0)

Trials studying CALY-002

News(0)

Report a data issue

comments(0)